Fulcrum Therapeutics Stock Forecast - Price Action Indicator
| FULC Stock | USD 3.44 0.19 5.85% |
Fulcrum Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Fulcrum Therapeutics stock prices and determine the direction of Fulcrum Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Fulcrum Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Fulcrum |
| Check Fulcrum Therapeutics Volatility | Backtest Fulcrum Therapeutics | Information Ratio |
Fulcrum Therapeutics Trading Date Momentum
| On November 25 2024 Fulcrum Therapeutics was traded for 3.44 at the closing time. The top price for the day was 3.56 and the lowest listed price was 3.24 . The trading volume for the day was 957.9 K. The trading history from November 25, 2024 did not affect price variability. The overall trading delta against the current closing price is 3.20% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Fulcrum Therapeutics to competition |
Other Forecasting Options for Fulcrum Therapeutics
For every potential investor in Fulcrum, whether a beginner or expert, Fulcrum Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Fulcrum Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Fulcrum. Basic forecasting techniques help filter out the noise by identifying Fulcrum Therapeutics' price trends.Fulcrum Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Fulcrum Therapeutics stock to make a market-neutral strategy. Peer analysis of Fulcrum Therapeutics could also be used in its relative valuation, which is a method of valuing Fulcrum Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Fulcrum Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Fulcrum Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Fulcrum Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Fulcrum Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Fulcrum Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fulcrum Therapeutics shares will generate the highest return on investment. By undertsting and applying Fulcrum Therapeutics stock market strength indicators, traders can identify Fulcrum Therapeutics entry and exit signals to maximize returns.
Fulcrum Therapeutics Risk Indicators
The analysis of Fulcrum Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Fulcrum Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting fulcrum stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.21 | |||
| Standard Deviation | 8.77 | |||
| Variance | 76.92 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Fulcrum Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fulcrum Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fulcrum Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fulcrum Therapeutics Stock:Check out Historical Fundamental Analysis of Fulcrum Therapeutics to cross-verify your projections. For information on how to trade Fulcrum Stock refer to our How to Trade Fulcrum Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fulcrum Therapeutics. If investors know Fulcrum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fulcrum Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.29) | Revenue Per Share 1.317 | Quarterly Revenue Growth 89.909 | Return On Assets (0.07) | Return On Equity (0.07) |
The market value of Fulcrum Therapeutics is measured differently than its book value, which is the value of Fulcrum that is recorded on the company's balance sheet. Investors also form their own opinion of Fulcrum Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Fulcrum Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fulcrum Therapeutics' market value can be influenced by many factors that don't directly affect Fulcrum Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fulcrum Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulcrum Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fulcrum Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.